News

FDA Clears Caretaker Medical’s Wireless Platform for Continuous Noninvasive Blood Pressure and Hemodynamic Monitoring

Caretaker Medical, a pioneer in wireless “beat by beat” continuous, non-invasive, advanced patient monitoring, announced U.S. Food and Drug Administration (FDA) clearance of the company’s next-generation VitalStream™ wireless blood pressure and hemodynamic monitoring platform.

Continuous monitoring of blood pressure is of great importance to detect and treat dynamic changes. Traditionally, blood pressure is measured intermittently with traditional cuffs that miss dangerous blood pressure changes, or it is measured continuously with an invasive arterial line, which is costly, requires a skilled clinician, and is difficult to use. VitalStream was designed to eliminate monitoring gaps associated with intermittent spot-check hemodynamic and vital sign measurements.

The VitalStream wireless platform expands the company’s clinically validated PDA™ waveform analysis technology and AI algorithms to measure blood pressure and hemodynamic parameters with every heartbeat, providing an uninterrupted stream of real-time data that eliminates “blind spots” between manual spot-check measurements, without limiting patient mobility.

“Accurate, non-invasive hemodynamic monitoring is certainly preferred to invasive A-lines in most patient populations. My use of the VitalStream monitor in the OR demonstrates compelling benefits in patient comfort, simplicity of use, and continuous, accurate, actionable data,” said Karen Boretsky, M.D., assistant professor of anesthesia at Harvard Medical School and senior associate in perioperative anesthesia, critical care, and pain medicine.

Utilizing a low-pressure finger sensor, VitalStream is a non-invasive alternative to A-lines and arterial catheters, enabling ICU-grade patient monitoring at all points of care to provide clinicians with streaming patient data for early indications of patient deterioration, faster life-saving interventions, and better treatment decisions. VitalStreams’s hemodynamics, waveforms, and vital sign data can be streamed remotely to the company’s mobile app or secure cloud portal, or integrated into other monitoring systems and EMRs with their FDA-cleared software interface SDKs.

“Intraoperative hypotension is common during noncardiac surgery and associated with 30-day major adverse events,” said Ashish Khanna, M.D., associate professor, vice chair for Research, Department of Anesthesiology, Section on Critical Care Medicine at Wake Forest School of Medicine Center. “The ability to noninvasively see beat-by-beat blood pressure and hemodynamic deterioration in real time allows us to make early interventions and potentially improve outcomes.”

More than 150 clinical customers throughout the world have been using Caretaker Medical’s previous generation beat-by-beat blood pressure and vital signs monitor across the full continuum of care, including OR, ICU, ER, COVID-19, Infusion, Sleep Lab, NeuroPsych, Pharma Drug Trials, and remote Hospital-at-Home.

“This is our fourth FDA Clearance expanding our wireless platform and enhancing our core continuous waveform technology and artificial intelligence algorithms,” said Jeff Pompeo, CEO, Caretaker Medical. “VitalStream sets a new standard in beat-by-beat hemodynamics in terms of accuracy, cost, simplicity of use, patient comfort, and streamlined workflow. We’re delivering ICU-grade monitoring that surpasses the most stringent regulatory certifications and clinical accuracy validation requirements to help improve outcomes at all points of care.”

This next-generation VitalStream platform expands on the company’s previous FDA-cleared Caretaker4 wireless patient monitor and PDA and AI algorithms by adding advanced hemodynamics, automated NEWS/MEWS early warning scores, higher resolution data and waveforms, ultra-fast 30-second auto-calibration and setup time, streamlined clinical workflow, more data connectivity options and a smaller wearable form factor.

The VitalStream Wireless Hemodynamic Monitor is available immediately in the United States directly from the company and its distribution partners, and will be available in Europe and Asia next year.

Recent News

12/05/2022

Danville organization invests in Blacksburg’s CytoRecovery medical cell sorting company

Danville’s investment might mean a CytoRecovery presence in Danville, such as office operations or an internship at Danville Community College. CytoRecovery’s cell sorting could improve understanding of disease and development of drugs. CytoRecovery, an early-stage company that invented and patented less invasive cell sorting, will be able to bring its cell research platform to market

12/01/2022

Ceres Nanosciences Receives $1.4M From NIH RADx Initiative to Add Five Additional Wastewater-Based Epidemiology Centers of Excellence

MANASSAS, Virginia – Ceres Nanosciences (Ceres), a privately held company that makes innovative products to improve life science research and diagnostic testing, is announcing today that it is expanding the network of wastewater-based epidemiology centers of excellence that was established with support from the National Institutes of Health (NIH) RADx® initiative. With a new $1.4

11/16/2022

Alliance for Building Better Medicine Names Joy Polefrone as Executive Director

Joy Polefrone, Ph.D. will Lead the Organization in Its Mission to Create a Reliable Supply of Safe, High-Quality, and Affordable Medicines in the U.S. Richmond/Petersburg– Alliance for Building Better Medicine, a coalition of public and private sector stakeholders in the Richmond-Petersburg region, today announced that it has appointed Joy Marie Polefrone, Ph.D., as the organization’s executive director.